DNA treatment cuts bad cholesterol by nearly 50% without statins
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice after a single injection.
We haven't written up this one. ScienceDaily Health has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- DNA treatment cuts bad cholesterol by nearly 50% without statins sciencedaily.com
